Working… Menu

Gene Therapy for Achromatopsia (CNGA3) (CNGA3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03758404
Recruitment Status : Completed
First Posted : November 29, 2018
Last Update Posted : June 25, 2021
Janssen Research & Development, LLC
Information provided by (Responsible Party):
MeiraGTx UK II Ltd

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 10, 2021
Actual Study Completion Date : June 10, 2021